Trump launches "TrumpRx" program to cut prices of Wegovy and Zepbound, making weight-loss drugs more affordable for Americans ...

A new deal with the White House is set to lower the cost of certain obesity drugs including Zepbound, but when will prices actually decrease?

Prices are supposed to come down on weight loss drugs like Zepbound and Wegovy, but when will you see a change in your ...

Eli Lilly and Novo Nordisk have agreed to sell their weight loss drugs, Wegovy and Zepbound, through the new TrumpRx ...

One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...

Under its terms, those products will be sold by their developers through a planned national online drug platform called TrumpRx at a steep discount to certain current rates (under agreements set with ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity treatments Zepbound and Wegovy. Here’s what we know.

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new pricing initiative.

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

The Trump administration plans to announce a deal with pharmaceutical companies to sell discounted weight-loss drugs through TrumpRx, a government-run platform.

Eli Lilly and Company is making waves across multiple fronts, demonstrating a comprehensive growth strategy that extends well ...